drugset / Trial / NCT00855439
Evaluation of Exenatide in Patients With Diabetic Neuropathy
Completed
46 enrolled
University of Michigan
Amylin Pharmaceuticals, LLC. · collabEli Lilly and Company · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will look at whether or not the medication exenatide improves signs and symptoms of diabetic peripheral neuropathy in people with type 2 diabetes and mild to moderate diabetic peripheral neuropathy.
Timeline
- Start
- 2008-06
- Primary completion
- 2014-05
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exenatide | Peptide | — | Subcutaneous |
| Comparator | insulin glargine | Protein / enzyme biologic | — | — |